We are live on !
Find out more
NED
Nancy E. Dempze Portfolio holdings
AUM
$209M
Turnover
11.34%
1-Year Est. Return
33.81%
This Fund
S&P 500
This Quarter Est. Return
+3.63%
1 Year Est. Return
+33.81%
3 Year Est. Return
+83.09%
5 Year Est. Return
+106.57%
10 Year Est. Return
+388.31%
AUM
$146M
AUM Growth
+$14.4M
(+11%)
Cap. Flow
+$11M
Cap. Flow % of AUM
Cap. Flow %
7.56%
Top 10 Holdings %
Top 10 Hldgs %
38.97%
Holding
81
New
19
Increased
31
Reduced
18
Closed
–
Avg Time Held
3.9
years
Top 10 Avg Time Held
2.9
years
Top 20 Avg Time Held
4.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$1.34M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
+$1.07M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$815K |
| 4 |
Ball Corp
BALL
|
+$607K |
| 5 |
McCormick & Company Non-Voting
MKC
|
+$606K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$1.02M |
| 2 |
Novartis
NVS
|
+$628K |
| 3 |
NVIDIA
NVDA
|
+$550K |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$125K |
| 5 |
Procter & Gamble
PG
|
+$109K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.64% |
| 2 | Healthcare | 17.91% |
| 3 | Miscellaneous | 14.84% |
| 4 | Industrials | 11.49% |
| 5 | Consumer Discretionary | 9.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
NVIDIA
NVDA
$4.94T
| $10.2M | 6.99% |
82,385
-5,435
| -6% | -$550K |
2019 Q4
18 quarters
|
|
2
Microsoft
MSFT
$3.88T
| $6.57M | 4.51% |
14,692
+514
| +4% | +$217K |
2015 Q4
34 quarters
|
|
3
Apple
AAPL
$5.03T
| $6.47M | 4.44% |
30,707
+517
| +2% | +$96.4K |
2015 Q4
34 quarters
|
|
|
4
Alphabet (Google) Class A
GOOGL
$3.44T
| $5.88M | 4.03% |
32,264
-744
| -2% | -$125K |
2015 Q4
34 quarters
|
|
5
Analog Devices
ADI
$202B
| $5.14M | 3.52% |
22,499
-110
| -0.5% | -$23.5K |
2016 Q3
31 quarters
|
|
6
Mastercard
MA
$556B
| $4.76M | 3.27% |
10,800
+29
| +0.3% | +$13.2K |
2015 Q4
34 quarters
|
|
7
Amazon
AMZN
$2.6T
| $4.7M | 3.23% |
24,325
+525
| +2% | +$96.4K |
2018 Q4
22 quarters
|
|
8
Advanced Micro Devices
AMD
$824B
| $4.47M | 3.07% |
27,586
-608
| -2% | -$97.8K |
2022 Q1
9 quarters
|
|
9
Danaher
DHR
$163B
| $4.34M | 2.98% |
17,368
+172
| +1% | +$43.5K |
2015 Q4
34 quarters
|
|
10
Automatic Data Processing
ADP
$116B
| $4.27M | 2.93% |
17,892
+105
| +0.6% | +$25.8K |
2015 Q4
34 quarters
|
|
11
Fiserv Inc
FISV
$26.6B
| $4.19M | 2.87% |
28,084
+85
| +0.3% | +$12.9K |
2015 Q4
34 quarters
|
|
|
12
Procter & Gamble
PG
$374B
| $4.07M | 2.8% |
24,706
-668
| -3% | -$109K |
2015 Q4
34 quarters
|
|
13
Abbott
ABT
$184B
| $3.89M | 2.67% |
37,447
+890
| +2% | +$94.4K |
2015 Q4
34 quarters
|
|
14
TJX Companies
TJX
$154B
| $3.81M | 2.61% |
34,568
+477
| +1% | +$48K |
2015 Q4
34 quarters
|
|
15
Home Depot
HD
$328B
| $3.79M | 2.6% |
11,012
+772
| +8% | +$263K |
2015 Q4
34 quarters
|
|
16
UnitedHealth
UNH
$365B
| $3.78M | 2.59% |
7,420
+294
| +4% | +$144K |
2019 Q4
18 quarters
|
|
17
Johnson & Johnson
JNJ
$658B
| $3.72M | 2.55% |
25,434
+2,090
| +9% | +$311K |
2015 Q4
34 quarters
|
|
18
Canadian National Railway
CNI
$74.2B
| $3.58M | 2.46% |
30,284
-57
| -0.2% | -$7.14K |
2015 Q4
34 quarters
|
|
19
Rockwell Automation
ROK
$48.4B
| $3.43M | 2.36% |
12,473
+463
| +4% | +$125K |
2015 Q4
34 quarters
|
|
20
AptarGroup
ATR
$8.7B
| $3.2M | 2.2% |
22,756
+180
| +0.8% | +$26K |
2015 Q4
34 quarters
|
|
21
Xylem
XYL
$21.2B
| $3.18M | 2.18% |
23,428
+225
| +1% | +$30.6K |
2015 Q4
34 quarters
|
|
22
RTX Corp
RTX
$270B
| $2.96M | 2.03% |
29,461
+397
| +1% | +$41K |
2015 Q4
34 quarters
|
|
23
Becton Dickinson
BDX
$53.9B
| $1.95M | 1.34% |
8,331
-205
| -2% | -$48.3K |
2015 Q4
34 quarters
|
|
|
24
Visa
V
$773B
| $1.52M | 1.04% |
5,789
+4,875
| +533% | +$1.34M |
2023 Q1
5 quarters
|
|
25
Chevron
CVX
$459B
| $1.44M | 0.99% |
9,232
+3,415
| +59% | +$545K |
2019 Q1
21 quarters
|
|
Similar funds
HFS
IF
Nancy E. Dempze's Q2 2024 Portfolio in Review
As of Q2 2024, Nancy E. Dempze held 81 positions worth $146M, up 11% from $131M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Nancy E. Dempze deployed $11M of net new capital in Q2 2024, opening 19 new positions and adding to 31 existing holdings. Its largest new stake was Regeneron Pharmaceuticals: 1,100 shares worth $1.16M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 29% a quarter earlier, followed by Healthcare and Miscellaneous.
On the sell side, the largest reduction was Nike, an estimated $1.02M trimmed.
- Nancy E. Dempze's largest Q2 2024 buy was Regeneron Pharmaceuticals: 1,100 shares worth $1.16M.
- Nancy E. Dempze added most to Visa in Q2 2024, an estimated $1.34M increase.
- Nancy E. Dempze's biggest Q2 2024 reduction was Nike, cutting an estimated $1.02M.
- Nancy E. Dempze's ten largest holdings make up 39% of its $146M portfolio in Q2 2024.
- Nancy E. Dempze opened 19 new positions and closed 0 in Q2 2024.
- Nancy E. Dempze's portfolio value rose 11% quarter-over-quarter to $146M.
Based on Nancy E. Dempze's 13F filing for Q2 2024, filed 12 Aug 2024.